Moreover, we found that SHP-1 and EGFR not only were correlated with each other but also predicted the OS of patients with breast cancer, thus highlighting the value of SHP-1 as a novel prognostic biomarker in human breast cancer. This evidence concerns the gene EGFR and breast carcinoma.